Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Prenetics Global Ltd PRE.P.I


Primary Symbol: PRE Alternate Symbol(s):  PREJF

Healthcare
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients.


NDAQ:PRE - Post by User

Prenetics Global Ltd > Pacific lawyers in Court of Queen Bench of Alberta on Jul 04
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by Danielmaon Jun 15, 2017 11:43am
461 Views
Post# 26366355

Pacific lawyers in Court of Queen Bench of Alberta on Jul 04

Pacific lawyers in Court of Queen Bench of Alberta on Jul 04I am going to Court of Queen Bench of Alberta on July 04. My fight with PRE will be your fight. If you have any document which can help us in the court, please email it to fmalekzad@gmail.com.
regards
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities